
|Articles|June 1, 2002
New data drive home key points about testis tumors
The recent review of a large series of patients with bilateral testiculargerm cell cancer treated at Memorial Sloan-Kettering Cancer Center (seearticle, page 8) is interesting and important to practicing urologists whoencounter this disease for three key reasons. First, this study, involving a very large series of patients with bilateraltestis tumors, corroborates the following facts that are well recognizedabout bilateral testicular cancer:
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS
4
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
5






